A PROGNOSTIC IMMUNOTHERAPY MODEL FOR 4T1 BREAST CANCER WITH COMBINED CYCLOPHOSPHAMIDE AND TLR AGONIST

DOI10.1142/S0218339020500035zbMath1445.92140OpenAlexW3008411263MaRDI QIDQ5120283

Xuefang Li, Danhua He, Wei Nan Xu, Jian-Xin Xu

Publication date: 9 September 2020

Published in: Journal of Biological Systems (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1142/s0218339020500035

zbMATH Keywords

breast cancerimmunotherapyMDSCsTLR agonists

Mathematics Subject Classification ID

Medical applications (general) (92C50) Systems biology, networks (92C42)

Cites Work

• Optimal control in a model of dendritic cell transfection cancer immunotherapy
• A mathematical prognosis model for pancreatic cancer patients receiving immunotherapy
• Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis
• A MATHEMATICAL MODEL OF IMMUNE RESPONSE TO TUMOR INVASION INCORPORATED WITH DANGER MODEL
• OPTIMAL CONTROL OF MIXED IMMUNOTHERAPY AND CHEMOTHERAPY OF TUMORS
• AI 2005: Advances in Artificial Intelligence

This page was built for publication: A PROGNOSTIC IMMUNOTHERAPY MODEL FOR 4T1 BREAST CANCER WITH COMBINED CYCLOPHOSPHAMIDE AND TLR AGONIST